ELCO MARQUEZ: Open Payments
NPI 1790542165 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 58 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $449 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $212 |
| LivaNova USA, Inc. | 3 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $162 |
| Neurocrine BioSciences, Inc. | 7 | $146 |
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| Teva Pharmaceuticals USA, Inc. | 4 | $115 |
| Alkermes, Inc. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| TMS NeuroHealth Centers Inc. | 1 | $45 |
Products named: VRAYLAR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, CAPLYTA, INGREZZA, AUSTEDO XR, SPRAVATO, TRINTELLIX, REXULTI.
Industry payments across FL — which companies pay providers there.
